Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)

Table 4 Self-reported outcomes among patients, by country

	All patients N = 4,341	China N = 373	Germany N = 149	India N = 918	Mexico N = 206	Russia N = 240	Saudi Arabia N = 226	USA N = 540
	mean ± SD
Diabetes Knowledge Test score^a	5 ± 2	7 ± 2	6 ± 2	4 ± 2	4 ± 2	6 ± 2	4 ± 2	5 ± 2
Diabetes Distress Scale score^b	38 ± 19	28 ± 11	24 ± 9	37 ± 19	39 ± 21	49 ± 18	51 ± 17	33 ± 15
Interpersonal Processes of Care score^c	3 ± 0.5	3 ± 0.5	3 ± 0.5	3 ± 0.5	3 ± 0.6	3 ± 0.5	3 ± 0.5	3 ± 0.4
Self-monitoring of blood glucose^d	3 ± 3	2 ± 2	5 ± 2	1 ± 2	3 ± 3	4 ± 2	2 ± 2	5 ± 3

^a The Diabetes Knowledge Test’s summary score ranges from 0 (no questions correct) to 9 (all questions correct)
^b The Diabetes Distress Scale score ranges from 17 (no distress) to 102 (severe distress)
^c The Interpersonal Processes of Care score ranges from 1 (poor relationship with healthcare provider) to 5 (good relationship with healthcare provider)
^d The self monitoring of blood glucose value ranges from 0 (checked blood glucose on no days of the week as recommended by healthcare provider) to 7 (checked blood glucose on all 7 days of the week as recommended by healthcare provider)

ISSN: 1472-6823